The potential of PAI-1 expression in needle biopsies as a predictive marker for prostate cancer
The relative abundance of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in transurethral resections of the prostate (TURP) has been shown to correlate with disease state. The objective of this study was to assay for uPA and PAI-1 in prostate needle biopsies...
Main Authors: | Antonio Serafin, Lothar Böhm, Pedro Fernandez, Daniel Achel, John Akudugu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2016-12-01
|
Series: | Cogent Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2331205X.2016.1183275 |
Similar Items
-
A multi-parameter approach for predicting prostate cancer
by: Antonio Serafin, et al.
Published: (2017-01-01) -
Prostate biopsy in a rural hospital: Our experience
by: Suresh K Jariwala
Published: (2017-01-01) -
Predicting Significance of Blood Parameters in Diagnosis of Prostate Carcinoma in a Tertiary Centre in Udaipur, Rajasthan
by: Gulshan Kumar Mukhiya, et al.
Published: (2021-04-01) -
Transrectal ultrasound and needle biopsy of the prostate
by: Tomaž Smrkolj
Published: (2016-01-01) -
Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)